Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells

M Benathan - Melanoma research, 1996 - journals.lww.com
Abstract The catechol 5-S-cysteinyldopa (5-S-CD) is produced in large amounts in
metastatic malignant melanoma. To further understand the mechanism of formation of 5 …

Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.

M Benathan - Melanoma research, 1996 - folia.unifr.ch
English The catechol 5-S-cysteinyldopa (5-S-CD) is produced in large amounts in metastatic
malignant melanoma. To further understand the mechanism of formation of 5-S-CD, we …

[引用][C] Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells

M Benathan - Melanoma Research, 1996 - cir.nii.ac.jp
Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in
human melanoma cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells

M Benathan - Melanoma research, 1996 - pubmed.ncbi.nlm.nih.gov
The catechol 5-S-cysteinyldopa (5-S-CD) is produced in large amounts in metastatic
malignant melanoma. To further understand the mechanism of formation of 5-S-CD, we …

Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.

M Benathan - Melanoma Research, 1996 - europepmc.org
The catechol 5-S-cysteinyldopa (5-S-CD) is produced in large amounts in metastatic
malignant melanoma. To further understand the mechanism of formation of 5-S-CD, we …

Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.

M Benathan - Melanoma research, 1996 - sonar.ch
English The catechol 5-S-cysteinyldopa (5-S-CD) is produced in large amounts in metastatic
malignant melanoma. To further understand the mechanism of formation of 5-S-CD, we …